Ability Pharmaceuticals SA

Where the EU money came from

Funding by EU programme. Amounts are Ability Pharmaceuticals SA's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Ability Pharmaceuticals SA led 1 of them as coordinator. Each links to the official record.

• PHOENIXPartner

  Phase I/II trial of an Oral ER-stress iNducer in relapsed/refractory neuroblastoma and paediatric solid tumours

  Horizon Europe · 2026–2032 · Project on CORDIS ↗

  €1.9Mtheir share
• PanC-ASAPCoordinator

  AbilityPharma: Accelerating Solutions for Pancreatic Cancer

  Horizon 2020 · 2020–2023 · Project on CORDIS ↗

  €2.3Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Universitat Autonoma de BarcelonaSpain · 1 shared project
• Masarykova univerzitaCzech Republic · 1 shared project
• Institut CurieFrance · 1 shared project
• Region HovedstadenDenmark · 1 shared project
• Institut Gustave RoussyFrance · 1 shared project
• Ecrin European Clinical Research Infrastructure NetworkFrance · 1 shared project
• Fundacio Hospital Universitari Vall D'Hebron - Institut de RecercaSpain · 1 shared project
• Fundacion Para la Investigacion de Malaga en Biomedicina y SaludSpain · 1 shared project
• Echalliance Company Limited By GuaranteeIreland · 1 shared project
• Fundacion Para la Investigacion Biomedica del Hospital Universiatrio la PazSpain · 1 shared project
• Shine 2europe LdaPortugal · 1 shared project
• Fundacion Para la Investigacion Biomedica Hospital Infantil Universitario Nino JesusSpain · 1 shared project
• Children'S Health IrelandIreland · 1 shared project
• Fakultni Nemocnice BrnoCzech Republic · 1 shared project
• Fundación CRIS de Investigación para Vencer el CáncerSpain · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• drug discovery
• oncology
• pancreatic cancer